Read more
"Diabetes Mellitus: Impact on Bone, Dental and Musculoskeletal Health focuses on the under recognized and managed conditions associated with diabetes, including impacts on bone health, dental health, hand, and foot disorders, wounds, infections, and musculoskeletal disorders. A full understanding of the relationship of diabetes to skeletal disorders remains elusive and many physicians who deal with such issues are unclear about causes and management. While the macro- and microvascular complications associated with diabetes mellitus are well known, complications associated with bone, dental and musculoskeletal health are not. Endocrinologists, primary care physicians, geriatricians, podiatrists, dentists, and researchers interested in diabetes mellitus associated bone, dental and musculoskeletal disorders will find this to be a comprehensive tome on the topic."--Amazon.ca
List of contents
1. Diabetes mellitus and its many complications
Section I: Impact on bone health
2. Diabetes mellitus: How being too sweet leads to skeletal fragility
3. Mechanisms of skeletal fragility in diabetes mellitus
4. Impact of glucose-lowering medications on bone health in diabetes
5. The combined impact of diabetes mellitus and chronic kidney disease on mineral metabolism and bone fragility
6. Diabetes mellitus-Infections and fracture healing
Section II: Impact on dental health
7. Diabetes mellitus-Dental implants and periodontal disease
8. Diabetes mellitus and its association with infection and osteonecrosis of the jaw
Section III: Impact on musculoskeletal health
9. Diabetes mellitus and sarcopenia
10. Diabetes mellitus: Impact on common hand disorders
11. Musculoskeletal disorders associated with diabetes
12. Neuropathic arthropathy (Charcot joint)
13. Diabetes mellitus and muscle infarction
14. Diabetes mellitus and osteoarthritis
15. Diabetes mellitus and gout
About the author
MengHee Tan, MD, FACP, FRCP [C], [L], [E], FACE, is Professor Emeritus of Internal Medicine, Division of Metabolism, Endocrinology & Diabetes, University of Michigan. Earlier in academia at Dalhousie University, Halifax, Canada, he was Professor of Medicine and Biochemistry and Head, Division of Endocrinology & Metabolism. He was also Head, Department of Medicine, Halifax Infirmary and Camp Hill Medical Center. After leaving Dalhousie, he became Medical Director of Diabetes Disease Management at Becton Dickinson and Company. Later, he was a Distinguished Medical Fellow at Lilly Research Laboratories and Senior Global Medical Director, Diabetes Endocrine Platform Team at Eli Lilly and Company. His research interests span from unravelling the biology of skeletal muscle to uncovering new knowledge on pharmacotherapy for people with diabetes and dyslipidemias. He has published over 200 research/clinical papers and chapters on diabetes, lipoprotein metabolism, and endocrinology. He was the inaugural Editor-in-Chief of Clinical Diabetes and Endocrinology.
He is past President of the Canadian Diabetes Association, Chair of the Canadian Diabetes Advisory Board, and Vice-President of the International Diabetes Federation. He received the Harold Rifkin Award from the American Diabetes Association and the Charles H Best Award from the Canadian Diabetes Association.
